GNH USA

Europe — EMA

Icatibant Ratiopharm

GNH USA supplies Icatibant Ratiopharm (Icatibant Acetate), a bradykinin B2 receptor antagonist for hereditary angioedema attacks. Request a quote for supply.

Icatibant Acetate

Request sourcing

1
Pack/s

What is Icatibant Acetate?

Icatibant acetate, the active ingredient in Icatibant Ratiopharm, is a bradykinin B2 receptor antagonist presented as a subcutaneous injection for subcutaneous use. It treats hereditary angioedema (HAE) attacks in patients with a confirmed diagnosis.

GNH USA supplies Icatibant Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Icatibant Acetate used for?

Icatibant Ratiopharm is used to treat conditions mediated by excessive bradykinin activity, primarily hereditary angioedema.

Hereditary angioedema (HAE) attacks: rapid reduction of swelling and pain during acute episodes.

What are the side effects of Icatibant Acetate?

Common Side Effects: - Injection site pain or erythema - Local swelling or induration - Nausea or mild headache - Dizziness or fatigue

Serious or Rare Side Effects: - Hypersensitivity reactions including rash or urticaria - Anaphylaxis or severe allergic response - Marked hypotension - Angioedema unrelated to HAE - Thrombocytopenia or abnormal bleeding - Severe infection at the injection site

What precautions apply to Icatibant Acetate?

Before initiating therapy, confirm the diagnosis of hereditary angioedema and assess for prior hypersensitivity to bradykinin antagonists.

- Allergy assessment: avoid in patients with known B2‑receptor antagonist allergy. - Monitoring: observe for signs of severe hypotension or anaphylaxis after injection. - Concomitant therapy: use under medical supervision when combined with ACE inhibitors or other bradykinin‑modulating agents. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Icatibant Acetate interact with?

Icatibant may interact with drugs that influence bradykinin levels or vascular tone.

Major Interactions (Avoid): - ACE inhibitors: can increase bradykinin and heighten risk of angioedema. - Neprilysin inhibitors: may elevate bradykinin concentrations. - Other bradykinin B2 antagonists: additive pharmacologic effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may exacerbate swelling or pain. - Oral contraceptives: potential for altered vascular response. - Diuretics: monitor blood pressure changes. - Antihistamines: may mask early signs of hypersensitivity.

Frequently asked questions

What is Icatibant Ratiopharm used for?+
Icatibant Ratiopharm is prescribed for the acute treatment of hereditary angioedema (HAE) attacks. It works by rapidly reducing the swelling and pain that occur during an HAE episode, providing relief for patients with a confirmed diagnosis.
How does icatibant acetate work?+
Icatibant acetate is a selective antagonist of the bradykinin B2 receptor. By blocking this receptor, it prevents bradykinin‑mediated vasodilation and increased vascular permeability, which are the primary mechanisms that cause the swelling seen in HAE attacks.
What is the usual dose of Icatibant Ratiopharm?+
The dosage and administration schedule for Icatibant Ratiopharm are determined by the prescribing healthcare professional based on the patient’s clinical condition and regulatory guidelines. Patients should follow the prescriber’s instructions precisely.
Is Icatibant Ratiopharm safe during pregnancy or breastfeeding?+
Safety data for icatibant acetate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using the product.
How do I order Icatibant Ratiopharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and import documentation.
How does Icatibant compare with other HAE treatments?+
Icatibant is a bradykinin B2 receptor antagonist, whereas other approved HAE therapies include C1‑esterase inhibitor concentrates and kallikrein inhibitors. Icatibant’s subcutaneous route offers rapid onset of action and does not require plasma‑derived products, making it a distinct option for patients who prefer a synthetic agent.
What are the storage requirements for Icatibant Ratiopharm?+
Icatibant Ratiopharm should be stored at 2‑8 °C (refrigerated). Keep the product in its original packaging, protect it from light, and avoid freezing or shaking the vial to maintain stability.
How is Icatibant Ratiopharm administered?+
The medication is given by subcutaneous injection, typically into the abdomen or thigh. A healthcare professional or trained patient can perform the injection using the supplied pre‑filled syringe, following aseptic technique and the prescriber’s dosing instructions.
What are the most serious risks associated with Icatibant?+
Serious risks include hypersensitivity reactions such as anaphylaxis, severe hypotension, and rare cases of angioedema unrelated to HAE. Patients should be monitored closely after the first dose and instructed to seek immediate medical attention if they experience signs of a severe allergic reaction.
Who should not use Icatibant Ratiopharm?+
Icatibant is contraindicated in individuals with a known allergy to icatibant acetate or any component of the formulation. It should also be avoided in patients who have experienced severe hypersensitivity to other bradykinin B2 receptor antagonists.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Icatibant Acetate
Route
Subcutaneous Use
Manufacturer
Teva B.V
Origin
EU

Related products